{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:04:12Z","timestamp":1758845052973,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.urology.2021.10.015","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T19:20:58Z","timestamp":1635621658000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characterization of a Novel Implant Intended to Expand and Reshape the Prostatic Urethra for the Treatment of Benign Prostatic Hyperplasia: A Pre-Clinical Feasibility Study in the Canine Model"],"prefix":"10.1016","volume":"159","author":[{"given":"Bilal","family":"Chughtai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananth","family":"Punyala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshana S.","family":"Lata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald H.","family":"Maul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahra","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Rouselle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo R.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2021.10.015_bib0001","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0090-4295(98)00126-5","article-title":"Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group","volume":"51","author":"Lepor","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.10.015_bib0002","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.urology.2018.06.022","article-title":"A review of the FAERS Data on 5-Alpha reductase inhibitors: implications for postfinasteride syndrome","volume":"120","author":"Baas","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.10.015_bib0003","article-title":"Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia","volume":"11","author":"Pattanaik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2021.10.015_bib0004","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1464-410X.2008.07498.x","article-title":"Profile and management of patients treated for the first time for lower urinary tract symptoms\/benign prostatic hyperplasia in four European countries","volume":"101","author":"Fourcade","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.10.015_bib0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.sxmr.2018.02.003","article-title":"New and emerging technologies in treatment of lower urinary tract symptoms from benign prostatic hyperplasia","volume":"7","author":"Gupta","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.urology.2021.10.015_bib0006","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/bju.14249","article-title":"Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)","volume":"122","author":"Ray","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.10.015_bib0007","doi-asserted-by":"crossref","first-page":"k2338","DOI":"10.1136\/bmj.k2338","article-title":"Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial","volume":"361","author":"Abt","year":"2018","journal-title":"BMJ [Internet]"},{"key":"10.1016\/j.urology.2021.10.015_bib0008","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study","volume":"126","author":"McVary","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.10.015_bib0009","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","article-title":"WATER: a double-blind, randomized, controlled trial of Aquablation(\u00ae) vs transurethral resection of the prostate in benign prostatic hyperplasia","volume":"199","author":"Gilling","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.10.015_bib0010","article-title":"Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"2","author":"Hwang","year":"2019","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.urology.2021.10.015_bib0011","first-page":"7772","article-title":"Three year results of the prostatic urethral L.I.F.T. study","volume":"22","author":"Roehrborn","year":"2015","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2021.10.015_bib0012","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Can J Urol"},{"key":"10.1016\/j.urology.2021.10.015_bib0013","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1089\/end.2017.0224","article-title":"Holmium laser enucleation of the prostate after prostatic urethral lift surgery: feasibility and technical considerations from a multi-institutional case series","volume":"31","author":"McAdams","year":"2017","journal-title":"J Endourol"},{"key":"10.1016\/j.urology.2021.10.015_bib0014","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/bju.14608","article-title":"Second-generation of temporary implantable Nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up","volume":"123","author":"Porpiglia","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.10.015_bib0015","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00345-020-03140-z","article-title":"Second generation of temporary implantable Nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study","volume":"38","author":"Kadner","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2021.10.015_bib0016","article-title":"Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"3","author":"Kang","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2021.10.015_bib0017","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.14990","article-title":"Transfusion rates after 800 Aquablation procedures using various haemostasis methods","volume":"125","author":"Elterman","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.10.015_bib0018","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1098612X19838286","article-title":"Evaluation of postoperative complication rates in cats undergoing perineal urethrostomy performed in dorsal recumbency","volume":"22","author":"Watson","year":"2020","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.urology.2021.10.015_bib0019","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.urology.2010.10.041","article-title":"The outcomes of perineal urethrostomy with preservation of the dorsal urethral plate and urethral blood supply","volume":"77","author":"Myers","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2021.10.015_bib0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1748-5827.2012.01310.x","article-title":"Short- and long-term outcome after perineal urethrostomy in 86 cats with feline lower urinary tract disease","volume":"53","author":"Ruda","year":"2012","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.urology.2021.10.015_bib0021","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1748-5827.2005.tb00314.x","article-title":"Retrospective study of indications for and outcome of perineal urethrostomy in cats","volume":"46","author":"Bass","year":"2005","journal-title":"J Small Anim Pract"},{"key":"10.1016\/j.urology.2021.10.015_bib0024","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/pros.20814","article-title":"Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases","volume":"68","author":"Mubiru","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2021.10.015_bib0025","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1172\/JCI109532","article-title":"Comparison of spontaneous and experimentally induced canine prostatic hyperplasia","volume":"64","author":"DeKlerk","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.urology.2021.10.015_bib0026","series-title":"Benign Prostatic Hypertrophy [Internet]","first-page":"152","article-title":"Relationship of the origin of benign prostatic hypertrophy to prostatic structure of man and other mammals","author":"McNeal","year":"1983"},{"key":"10.1016\/j.urology.2021.10.015_bib0027","doi-asserted-by":"crossref","first-page":"547","DOI":"10.21037\/tau.2017.03.62","article-title":"Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models","volume":"6","author":"Sun","year":"2017","journal-title":"Transl Androl Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521009948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521009948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:38:10Z","timestamp":1758767890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429521009948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":25,"alternative-id":["S0090429521009948"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2021.10.015","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a Novel Implant Intended to Expand and Reshape the Prostatic Urethra for the Treatment of Benign Prostatic Hyperplasia: A Pre-Clinical Feasibility Study in the Canine Model","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2021.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}